Following the inhibition of insulin secretion by the increased serum values of somatostatin, patients with somatostatinoma can present hyperglycemic changes through glucose intolerance from modified fasting glucose to the onset of diabetes [124]. This evidence concerns the gene INS and diabetes mellitus.